C Difficile

8445 bookmarks
Custom sorting
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis - PubMed
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis - PubMed
Multiple sclerosis (MS) causes long-lasting, multifocal damage to the central nervous system. The complex background of MS is associated with autoimmune inflammation and neurodegeneration processes, and is potentially affected by many contributing factors, including altered composition and function …
·pubmed.ncbi.nlm.nih.gov·
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis - PubMed
Clostridioides difficile utilizes siderophores as an iron source and FhuDBGC contributes to ferrichrome uptake - PubMed
Clostridioides difficile utilizes siderophores as an iron source and FhuDBGC contributes to ferrichrome uptake - PubMed
This study is the first example of C. difficile growing with siderophores as the sole iron source and describes the characterization of the ferric hydroxamate uptake ABC transporter (FhuDBGC). This transporter shows specificity to the siderophore ferrichrome. While not required for pathogenes …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile utilizes siderophores as an iron source and FhuDBGC contributes to ferrichrome uptake - PubMed
Clostridioides difficile infection in neurosurgical patients in a national centre over 10 years: less common but associated with longer hospital stays - PubMed
Clostridioides difficile infection in neurosurgical patients in a national centre over 10 years: less common but associated with longer hospital stays - PubMed
CDI in neurosurgery patients differed from the wider hospital, with greater awareness of CDI testing. Longer LOS impacted bed utilisation with limited capacity. Robust surveillance supports proactive antimicrobial stewardship programmes in this vulnerable population.
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile infection in neurosurgical patients in a national centre over 10 years: less common but associated with longer hospital stays - PubMed
Pro-Survival Pathway Protects from C. difficile Toxin-Mediated Cell Death - PubMed
Pro-Survival Pathway Protects from C. difficile Toxin-Mediated Cell Death - PubMed
There is an urgent need for new non-antibiotic based treatment strategies for Clostridioides difficile infection. C. difficile toxin B (TcdB) is a virulent factor that is essential for causing disease. Here, we investigated whether a survival-signaling pathway could protect against TcdB. We found si …
·pubmed.ncbi.nlm.nih.gov·
Pro-Survival Pathway Protects from C. difficile Toxin-Mediated Cell Death - PubMed
Spatial-temporal simulation for hospital infection spread and outbreaks of Clostridioides difficile - PubMed
Spatial-temporal simulation for hospital infection spread and outbreaks of Clostridioides difficile - PubMed
Validated and curated datasets are essential for studying the spread and control of infectious diseases in hospital settings, requiring clinical information on patients' evolution and their location. The literature shows that approaches based on Artificial Intelligence (AI) in the development of cli …
·pubmed.ncbi.nlm.nih.gov·
Spatial-temporal simulation for hospital infection spread and outbreaks of Clostridioides difficile - PubMed
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
The results of this study demonstrate that fidaxomicin is highly effective against C. perfringens strains of canine and feline origin. Although fidaxomicin is currently considered a critically important antimicrobial that has not yet been licensed for veterinary use, we consider that the results rep …
·pubmed.ncbi.nlm.nih.gov·
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats - PubMed
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
This review summarizes the application of synthetic biology in intestinal microecology-based therapeutics for major chronic diseases and discusses the opportunities and challenges in the above process, providing clinical possibilities of synthetic biology technology applied in microecological therap …
·pubmed.ncbi.nlm.nih.gov·
Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives - PubMed
Microbiome dynamics in rheumatic diseases - PubMed
Microbiome dynamics in rheumatic diseases - PubMed
A deeper comprehension of the microbiome's connection to rheumatism holds potential for enhancing disease diagnosis and treatment. Targeted therapeutic approaches, including probiotics, fecal microbiota transplantation, and combination therapies with medications, offer promising avenues for disease …
·pubmed.ncbi.nlm.nih.gov·
Microbiome dynamics in rheumatic diseases - PubMed
Gut Frailty: Its Concept and Pathogenesis - PubMed
Gut Frailty: Its Concept and Pathogenesis - PubMed
Although the concept of gut frailty has not yet gained widespread recognition, we hope to propose more practical screening methods, diagnostic approaches, and specific interventions in the future.
·pubmed.ncbi.nlm.nih.gov·
Gut Frailty: Its Concept and Pathogenesis - PubMed
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Physical interactions between bacteria and phages provide valuable insights into the mechanisms of phage infection and may provide information on the use of phages as a therapeutic approach. In this study, we employed a combination of in vitro and whole-cell assays to examine the interactions betwee …
·pubmed.ncbi.nlm.nih.gov·
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell Assays - PubMed
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
The bacterial flagellum is involved in a variety of processes including motility, adherence, and immunomodulation. In the Clostridioides difficile strain 630Δerm, the main filamentous component, FliC, is post-translationally modified with an O-linked Type A glycan structure. Thi …
·pubmed.ncbi.nlm.nih.gov·
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241- cd0244 Mutant Strains - PubMed
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Seres Therapeutics reported its financials recently including the performance of it therapy, Vowst, as well as updates on its business and one of its investigational therapies.
·news.google.com·
Company Who Developed Oral Live Biotherapeutic Reports Earnings
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
Our results demonstrated for the first time the antimicrobial, anti-inflammatory, and anti-apoptotic effects of M. longifolia extract on C. difficile RT001 and its Tox-S. However, further research is needed to evaluate the potential application of M. longifolia extract on CDI tr …
·pubmed.ncbi.nlm.nih.gov·
Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001 - PubMed
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
Targeted metagenomic sequencing is an emerging strategy to survey disease- specific microbiome biomarkers for clinical diagnosis and prognosis. However, this approach often yields inconsistent or conflicting results due to inadequate study power and sequencing bias. We introduce Taxa4Meta, a bioinfo …
·pubmed.ncbi.nlm.nih.gov·
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease - PubMed
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
In the age of progressive antimicrobial resistance and increased difficulty combating infections in immunocompromised hosts, there has been renewed interest in the use of nontraditional therapeutics for infections. Herein, we review the use of investigational non-pharmaceutical anti-infective agents …
·pubmed.ncbi.nlm.nih.gov·
Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies - PubMed
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
While emerging evidence highlights the significance of gut microbiome in gastrointestinal infectious diseases, treatments like Fecal Microbiota Transplantation (FMT) and probiotics are gaining popularity, especially for diarrhea patients. However, the specific role of the gut microbiome in different …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases - PubMed
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed
The gut-brain axis (GBA) is a complex bidirectional communication network connecting the gut and brain. It involves neural, immune, and endocrine communication pathways between the gastrointestinal (GI) tract and the central nervous system (CNS). Perturbations of the GBA have been reported in many n …
·pubmed.ncbi.nlm.nih.gov·
Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders - PubMed